Global News

ACRES, GuideStar partner on biomedical research site sustainability

Tuesday, February 2, 2016

GuideStar Clinical Trials Management, a company providing support services and strategies for clinical research programs around the U.S., and the Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector, nonprofit organization building a multi-stakeholder-driven integrated global system for clinical research, have partnered to expand site accreditation and uniformity across the clinical research community to promote and reward excellence. 

[Read More]

The CRA life: Dedication, passion, adaptability

Monday, February 1, 2016

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

To achieve a level of expertise in a clinical research role, dedication that exceeds standard performance is required. It requires a passion for innovation, the willingness to work outside your position or comfort zone, and the ability to adapt what you’ve learned to align with regulatory standards. 

[Read More]

CRF Health appoints Claudine Paccio SVP

Tuesday, January 26, 2016

CRF Health, a global provider of eCOA solutions for the life sciences industry, announces the appointment of Claudine Paccio as the company’s senior vice president, Delivery Services. Paccio will head-up client delivery and development activities at CRF Health, where she will provide leadership, structure and processes to enhance the delivery of the company’s services and solutions to its rapidly growing customer base.

[Read More]

Virginia Bio expands board of directors

Tuesday, January 26, 2016

Virginia Bio, a statewide nonprofit association representing life science industry in the Commonwealth of Virginia, elected five new members to their board of directors for a term of three years. The election took place in December at the Virginia Bio Annual Membership in Richmond, Virginia.

[Read More]

BioClinica acquires Clinverse

Monday, January 25, 2016

BioClinica, a specialty clinical trials services and technology provider, has acquired Clinverse. The acquisition expands Bioclinica’s offerings into the growing market of automated financial management technology solutions for global clinical trials. Clinverse is the latest investment that Bioclinica has completed to build the company into a leading provider of solutions that bring quality and efficiency to every phase of clinical trial development.  

[Read More]

Alkermes has positive phase III results for ALKS 5461 in major depressive disorder

Monday, January 25, 2016

Alkermes has announced preliminary topline results from FORWARD-3 and FORWARD-4, the first two of three phase III efficacy studies to read out from the comprehensive FORWARD pivotal program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression. Neither of the two studies met the prespecified primary efficacy endpoint, which compared ALKS 5461 to placebo on the change from baseline on the Montgomery–Åsberg Depression Rating Scale (MADRS).

[Read More]